COMMUNIQUÉS West-GlobeNewswire

Publication relative à des notifications de transparence
30/05/2025
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 30 mai 2025 , 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la [...]
Publication relating to transparency notifications
30/05/2025
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), May 30, 2025 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure [...]
Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors
30/05/2025
SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the- [...]
COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders
30/05/2025
Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) today announced that it has entered into a resolution agreement (the “Resolution [...]
Celularity Receives Nasdaq Notice Regarding Form 10-Q
30/05/2025
FLORHAM PARK, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that on May 28, 2025, Nasdaq notified [...]
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
30/05/2025
WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen. [...]
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference
30/05/2025
SOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies [...]
Noom Launches Free Menopause Education Hub in Partnership with Menopause Advocate Tamsen Fadal
30/05/2025
Leveraging Noom’s evidence-based behavior change program, the Menopause Education Hub provides vital guidance for women experiencing the hormonal transitions of menopause. Tamsen Fadal joins Noom as the brand’s first- [...]
Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer
30/05/2025
SYNC-T Therapy SV-102 combines partial tumor oncolysis with a multi-target biologic drug to provide a novel, personalized therapeutic approach for the treatment of metastatic solid tumor cancers FORT LAUDERDALE, Fla. [...]
Shareholder Update
30/05/2025
May 30, 2025 Biodexa Pharmaceuticals PLC Shareholder Update Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative [...]
CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference
30/05/2025
BERKELEY HEIGHTS, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]
Radical Clean Solutions Ltd. Terminates Asset Purchase Agreement with AgriForce Growing Systems Ltd. and Files Lawsuit for Breach of Contract
30/05/2025
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Radical Clean Solutions Ltd. (“Radical” or the “Company”), a Nevada corporation headquartered on Long Island, New York, today announced that it has formally notified AgriForce [...]
Hapbee Launches Redesigned Mobile App with AI-Powered Discovery Engine, Expanded Vibe Library and Real-Time In-App Support to Enhance Personalization, Usability, and User Engagement
30/05/2025
Company Also Updates Status of Audited Financial Statements VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCQB: HAPBF), the digital wellness company specializing [...]
Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
30/05/2025
CLEVELAND, May 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Ph.D., Chief Executive Officer, and Madhav Vasanthavada, Ph.D., Chief Commercial Officer, will [...]
Specific Health Guidance Service Utilizing the "Lav" Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals!
30/05/2025
TOKYO, May 30, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ("MEDIROM," "we,” “us” or “our”), a holistic healthcare company based in Japan, announces that its subsidiary, MEDIROM MOTHER [...]
Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
30/05/2025
HANOVER, Md., May 30, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy [...]
PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla
30/05/2025
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Legend Senior Living® Grows Portfolio Across Kansas, Colorado, and Pennsylvania
30/05/2025
WICHITA, Kan., May 30, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a national senior housing provider headquartered in Wichita, Kansas, has announced it will assume management of four additional communities, [...]
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
30/05/2025
Fortress will receive ~$28 million shortly after closing and is eligible for an additional contingent value right (CVR) of up to $4.8 million, plus a 2.5% royalty on future net sales of UNLOXCYT™ (cosibelimab-ipdl) [...]

Pages